Radio-labeled receptor-binding peptides: A new class of radiopharmaceuticals
- 1 July 2000
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 30 (3) , 195-208
- https://doi.org/10.1053/snuc.2000.7441
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Yttrium-90 DOTATOC: first clinical resultsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Somatostatin receptor imaging and therapy of pancreatic endocrine tumorsAnnals of Oncology, 1999
- Neurotensin receptors in human neoplasms: High incidence in Ewing's sarcomasInternational Journal of Cancer, 1999
- Tumour uptake of the radiolabelled somatostatin analogue [DOTA 0 ,TYR 3 ]octreotide is dependent on the peptide amountEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapyAnnals of Oncology, 1999
- Internalization of radiolabelled [DTPA0]octreotide and [DOTA0, Tyr3]octreotideNuclear Medicine Communications, 1998
- Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancersInternational Journal of Cancer, 1997
- Indium-111 pentetreotide scintigraphy in malignant lymphomasEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- Studies on renal tubular protein reabsorption: Partial and near complete inhibition by certain amino acidsScandinavian Journal of Clinical and Laboratory Investigation, 1977